搜索
确认
取消
img img
Home4b

Home4b

img

Centre for Chinese Herbal Medicine Drug Development Limited

Funded by Innovation and Technology Commission (ITC) of the Hong Kong Government, Centre for Chinese Herbal Medicine Drug Development Limited (the Centre) was established in September 2020 to accelerate the development of Chinese Herbal Medicine (CHM)-based drugs, and serve as a strategic platform to promote collaborations among local and international researchers, institutions and industry. The Centre aims to achieve the goal by enhancing the quality of pre-clinical and clinical CHM research and transforming the results into pharmaceutical products for international markets. In particular, the Centre develops treatments and cures for diseases such as ulcerative colitis and chronic constipation. It also supports the incubation of new CHM-based pharmaceutical start-ups that will target the global market, and nurtures talent for CHM research in Hong Kong.

RESEARCH

PLATFORMS

Introducing our Technology Platforms for CHM Drug Development

Clinical Data Science Group (CDS)
Clinical Data Science Group (CDS)
The CDS Group is building its data assets based on comprehensive data generated from Chinese Medicine clinical trials...
Gut Microbiota and Metabolism Group (Gut@2M)
Gut Microbiota and Metabolism Group (Gut@2M)
The Gut@2M Group brings together experts in gut microbiome, pharmacology and Chinese Medicine. The Group will develop a programme...
Immunology and Gut Inflammation Group (GI@Immu)
Immunology and Gut Inflammation Group (GI@Immu)
Dysregulated immune response is the key driver of pathogenesis of inflammatory bowel disease (IBD). The GI@Immu Group conducts basic and translational research...
Chinese Medicine Pharmacognosy Group (CMPharma)
Chinese Medicine Pharmacognosy Group (CMPharma)
The CMPharma Group focuses on integration and combination of multi-discipline subjects and technologies...
AI-driven Drug Discovery Group (AI@2D)
AI-driven Drug Discovery Group (AI@2D)
AI@2D group, is using machine-learning technology with high quality dataset to develop generative and predictive models...
Drug Application Group (℞ App)
Drug Application Group (℞ App)
Investigational New Drug (IND) application is a crucial stage in drug research and development prior to the administering...
img
A Chinese herbal medicine based new drug CDD-2101
Research
Programmes
A Chinese herbal medicine based new drug CDD-2101
Chronic constipation is a common gastrointestinal disorder that affects physical and social functioning and significantly interferes with daily living and wellbeing...
A Chinese herbal medicine based new drug CDD-2103
Research
Programmes
A Chinese herbal medicine based new drug CDD-2103
Ulcerative colitis (UC) is one of the major subtypes of inflammatory bowel disease. This chronic disease primarily causes tissue damage ...

LATEST NEWS

Chief Executive of Macao visits HKBU Centre for Chinese Herbal Medicine Drug Development
National Medical Products Administration delegates visit CDD
Centre for Chinese Herbal Medicine Drug Development Limited and Beijing Tong Ren Tang collaborates to develop novel Chinese medicine

VIDEOS

Bian Zhaoxiang: Modernizing Traditional Medicine and Practice
Bian Zhaoxiang: Modernizing Traditional Medicine and Practice
Time of issue:
2023/02/11
創科新里程 II:藥研藥現
創科新里程 II:藥研藥現
Time of issue:
2023/02/25
Bian
Friday Beyond Spotlights S2E9 | Bian Zhaoxiang: Modernizing Traditional Medicine and Practice
Categories:
video
Time of issue:
2023/02/11
Views
0
Keyword:
創科新里程
香港浸會大學中藥創新研發中心,以「傳統智慧、創新藥物」為宗旨,將傳統複方中藥,轉化為創新處方藥物,促進中藥的標準化和國際化。研發中心根據疾病和病人體質的特徵,配合複方藥物作為應用,治療目前臨床未能根治的疾病。研究團隊主要研究項目為潰瘍性結腸炎,以及慢性便秘,期望複方中藥能夠根治這兩種疾病,並將有關藥物註冊成全球性處方藥物,造福人類。
Categories:
video
Time of issue:
2023/02/25
Views
0
Keyword:
中藥
浸大
創科
創新科技署
科研
Previous page
1

Centre for Chinese Herbal Medicine Drug Development Limited

Units 201-207, Building 15W, Hong Kong Science Park, Pak Shek Kok, New Territories, Hong Kong

©2021 Centre for Chinese Herbal Medicine Drug Development Limited